CD8A and hepatocellular carcinoma: The cytotoxicity of peripheral non-specific CD8+ T cells was also reduced in hepatitis B-related HCC patients (9.85 ± 1.16%) compared with in CHB patients (12.10 ± 0.90%) (P<0.0001, SNK-q tests, Figure 5A).